Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice

被引:35
|
作者
Tsai, Wan C. [2 ]
Hershenson, Marc B. [2 ,3 ]
Zhou, Ying [2 ]
Sajjan, Umadevi [1 ,2 ]
机构
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48105 USA
[3] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA
关键词
P; aeruginosa; Lung infection; Macrolide; Macrophage; Innate immunity; MUCOID PSEUDOMONAS-AERUGINOSA; AIRWAY EPITHELIAL-CELLS; ALVEOLAR MACROPHAGES; BIOFILM FORMATION; CFTR(-/-) MICE; MOUSE MODEL; INFECTION; RECEPTOR; CLARITHROMYCIN; PHAGOCYTOSIS;
D O I
10.1007/s00011-009-0015-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Azithromycin (AZM) has been used as an anti-inflammatory agent in the treatment of cystic fibrosis (CF), particularly those with chronic infection with P. aeruginosa (PA). To investigate mechanisms associated with the beneficial effects of AZM in CF, we examined bacterial load, cytokine levels, and clearance of inflammatory cells in CF mice infected with mucoid PA and treated with AZM. Gut-corrected Cftr (tm1Unc) -TgN(FABPCFTR)#Jaw CF mice infected with an alginate-overproducing PA CF-isolate were treated with AZM or saline and examined for survival of animals, lung bacterial load, inflammation, cytokine levels, and apoptotic cells up to 5 days post-infection. Administration of AZM (20 mg/kg) 24 h after the infection improved 5-day survival to 95% compared with treatment with saline (56%). AZM administration was associated with significant reductions in bacterial load, decreased lung inflammation, and increased levels of IFN-gamma. AZM increased macrophage clearance of apoptotic neutrophils from the lung. Azithromycin enhances bacterial clearance and reduces lung inflammation by improving innate immune defense mechanisms in CF mice.
引用
收藏
页码:491 / 501
页数:11
相关论文
共 50 条
  • [1] Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice
    Wan C. Tsai
    Marc B. Hershenson
    Ying Zhou
    Umadevi Sajjan
    Inflammation Research, 2009, 58 : 491 - 501
  • [2] Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
    Rachida Legssyer
    François Huaux
    Jean Lebacq
    Monique Delos
    Etienne Marbaix
    Patrick Lebecque
    Dominique Lison
    Bob J Scholte
    Pierre Wallemacq
    Teresinha Leal
    Respiratory Research, 7
  • [3] Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
    Legssyer, Rachida
    Huaux, Francois
    Lebacq, Jean
    Delos, Monique
    Marbaix, Etienne
    Lebecque, Patrick
    Lison, Dominique
    Scholte, Bob J.
    Wallemacq, Pierre
    Leal, Teresinha
    RESPIRATORY RESEARCH, 2006, 7 (1)
  • [4] Nebulized Hyaluronan Ameliorates Lung Inflammation in Cystic Fibrosis Mice
    Gavina, Manuela
    Luciani, Alessandro
    Villella, Valeria R.
    Esposito, Speranza
    Ferrari, Eleonora
    Bressani, Ilaria
    Casale, Alida
    Bruscia, Emanuela M.
    Maiuri, Luigi
    Raia, Valeria
    PEDIATRIC PULMONOLOGY, 2013, 48 (08) : 761 - 771
  • [5] Azithromycin reduces bronchial wall thickening in infants with cystic fibrosis
    Chen, Yuxin
    Charbonnier, Jean-Paul
    Andrinopoulou, Eleni-Rosalina
    Sly, Peter D.
    Stick, Stephen M.
    Tiddens, Harm A. W. M.
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (05) : 870 - 873
  • [6] Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice
    Lubamba, Bob
    Huaux, Francois
    Lebacq, Jean
    Marbaix, Etienne
    Dhooghe, Barbara
    Panin, Nadtha
    Wallemacq, Pierre
    Leal, Teresinha
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (04) : 266 - 273
  • [7] Azithromycin for cystic fibrosis
    Southern, KW
    Barker, PM
    EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (05) : 834 - 838
  • [8] Azithromycin and cystic fibrosis
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2022, 107 (08) : 739 - 739
  • [9] Azithromycin in cystic fibrosis
    Kastelik, JA
    Peckham, DG
    Conway, S
    EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (04) : 771 - 771
  • [10] Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice
    Wollin, Lutz
    Maillet, Isabelle
    Quesniaux, Valerie
    Ryffel, Bernhard
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42